We are live on ! Find out more
LENZ

LENZ Therapeutics
LENZ

60 hedge funds and large institutions have $587M invested in LENZ Therapeutics in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

18% more funds holding

Funds holding: 51 → 60 (+9)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

0.63% more ownership

Funds ownership: 8.21% → 8.85% (+0.63%)

40% less capital invested

Capital invested by funds: $981M → $587M (-$394M)

75% less funds holding in top 10

Funds holding in top 10: 4 → 1 (-3)

Holders
60
Holders Change
+9
Holders Change %
+17.65%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
29
Increased
12
Reduced
11
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$52.6M
2
BlackRock
BlackRock
New York
+$17.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.1M
4
SFM
Sphera Funds Management
Israel
+$10.7M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$8.6M

Top Sellers

Rank Fund Capital Flow
1
SM
SB Management
United Arab Emirates
-$30.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.22M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.2M
4
Goldman Sachs
Goldman Sachs
New York
-$4.24M
5
SCM
Suvretta Capital Management
New York
-$3.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
26
Cormorant Asset Management
Massachusetts
$3.26M – – –
State Street
27
State Street
Massachusetts
$3.22M +$4.16M +28,092 New
Northern Trust
28
Northern Trust
Illinois
$2.35M +$3.03M +20,457 New
Goldman Sachs
29
Goldman Sachs
New York
$1.22M -$4.24M -28,617 -73%
HS
30
HighVista Strategies
Massachusetts
$998K +$1.29M +8,701 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$876K +$1.13M +7,639 New
CCM
32
CAAS Capital Management
New York
$656K – – –
Charles Schwab
33
Charles Schwab
California
$653K +$842K +5,685 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$646K +$833K +5,628 New
N
35
Nuveen
North Carolina
$562K +$726K +4,902 New
Bank of America
36
Bank of America
North Carolina
$500K +$641K +4,330 +14,931%
GCM
37
Ghisallo Capital Management
Massachusetts
$246K -$529K -3,571 -62%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$193K +$248K +1,678 New
CAN
39
Cetera Advisor Networks
California
$187K +$241K +1,629 New
Deutsche Bank
40
Deutsche Bank
Germany
$153K +$198K +1,335 New
AIG
41
American International Group
New York
$146K +$188K +1,270 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$144K +$186K +1,254 New
CSS
43
Cubist Systematic Strategies
Connecticut
$142K +$184K +1,240 New
SG Americas Securities
44
SG Americas Securities
New York
$119K +$153K +1,035 New
MIM
45
MetLife Investment Management
New Jersey
$112K +$145K +980 New
JP Morgan Chase
46
JP Morgan Chase
New York
$102K +$132K +889 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$93K +$121K +814 New
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$85.1K +$110K +742 New
Point72 Asset Management
49
Point72 Asset Management
Connecticut
$82K -$106K -715 -50%
SO
50
STRS Ohio
Ohio
$60K +$78.3K +529 New
1
2
3 4

LENZ Hedge Fund Activity: Q3 2021 in Review

60 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in LENZ Therapeutics (LENZ) for Q3 2021, worth a combined $587M — down 40% from $981M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LENZ positions and 20 closed out — a net gain of 9 holders — while 12 added to existing stakes and 11 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $52.6M. The largest seller was SB Management, exiting entirely with an estimated $30.5M sold.

  • 60 institutional investors held LENZ Therapeutics (LENZ) as of Q3 2021, up from 51 in Q2 2021.
  • Funds reported $587M of LENZ Therapeutics stock for Q3 2021, down 40% quarter-over-quarter.
  • 29 funds opened new LENZ Therapeutics positions in Q3 2021 and 20 closed out, a net change of +9 holders.
  • The largest LENZ Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $52.6M added.
  • The largest LENZ Therapeutics seller in Q3 2021 was SB Management, an estimated $30.5M sold.

Based on aggregated 13F filings for Q3 2021.